Skip to content

    Announcements

    Exciting News for WebMD Members!

    We've been busy behind the scenes building new message boards for you. You'll have new and easier ways to find messages, connect with others, and share your stories.

    And, this will all be available on your smartphone or other mobile device!

    What Do You Need to Do?

    The message board you're used to will be closing in the coming weeks. While many of your boards will be making the move to our new home, your posts will not. Want to keep a discussion going? Save posts you want to continue (this includes your member profile story), so that you can re-post them in the new message boards.

    Keep an eye here and on your email inbox, we'll be back in touch soon to give you all the information you need!


    Yours in health,
    WebMD Message Boards Management

    LATE BREAKING NEWS! KEPPRA XR GOES GENERIC!
    avatar
    phylisfeinerjohnson posted:
    MORRISTOWN, N.J., Sept. 13, 2011 /PRNewswire/ Watson Laboratories, Inc. has confirmed today that it has launched Levetiracetam Extended-Release 500 mg and 750 mg tablets — the generic version of Keppra XR® — following approval of the Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration (FDA).

    Watson has begun shipping the product today. Keppra XR® is indicated to treat partial onset seizures in people 16 years of age and older with epilepsy.

    For further information, click on: http://finance.yahoo.com/news/Watson-Launches-Generic-prnews-2763217451.html?x=0&.v=1

    Phylis Feiner Johnson
    www.epilepsytalk.com
    Was this Helpful?
    3 of 3 found this helpful
    Reply


    Helpful Tips

    Make sure no changes are made to your medications…
    This letter has been created by the Epilepsy Foundation to make explicitly sure that no substitutions are made to your prescription without ... More
    Was this Helpful?
    4 of 4 found this helpful

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    For more information, visit the Duke Health Epilepsy Center